The insulin-like growth factor system and fetal growth restriction

Pediatric Endocrinology Reviews

Volumn 6, Issue 2, 2008, Pages 235-240

  Randhawa, Ruvdeep S ^a  

^a Riverside Medical Center   (United States)

Author keywords

Fetal growth; Insulin like growth factor 1; Insulin like growth factor 2; Insulin like growth factor binding protein; IUGR; SGA

Indexed keywords

INSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE CONTROL; GENE DELETION; GENE EXPRESSION SYSTEM; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; INTRAUTERINE GROWTH RETARDATION; MOLECULAR MECHANICS; NONHUMAN; NUTRIENT SUPPLY; PATHOGENESIS; POSTNATAL GROWTH; SIGNAL TRANSDUCTION; SMALL FOR DATE INFANT;

ANIMALS; ENVIRONMENT; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MODELS, BIOLOGICAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 58249104510     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Monzavi R, Cohen P. IGFs and IGFBPs: role in health and disease. Best Pract Res Clin Endocrinol Metab 2002;16:433-447
2. Cohen P, Rosenfeld RG. Growth Disorders. In: Textbook of Pediatric Endocrinology, 2nd edition, Editor: Sperling M 2002
3. Collett-Solberg PF, Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000;12:121-136
4. Cottett-Solberg PF, Rajah R, Weinzimer SA, Cohen P. The impact of IGF-binding proteins and IGFBP proteases on tissue growth. In: Johnston FE, Eveleth PB, Zemel B (ed). Human Growth in Context. London: Smith-Gordon 1999
5. Ferry Jr RJ, Cohen P. The Insulin-Like Growth Factor Axis in Pediatrics. Clin Pediatr Endocrinol 1999;8:1-10
6. Gluckman PD, Gunn AJ, Wray A, Cutfield WS, Chatetain PG, Guitbaud O, Ambler GR, Wilton P, Albertsson-Wikland K. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr 1992;121(6):920-923
7. Savage MO, Burren CP, Blair JC, Woods KA, Metherell L, Clark AJ, Camacho-Hubner C. Growth hormone insensitivity: pathophysiology, diagnosis, clinical variation and future perspectives Horm Res 2001;55(Suppl 2):32-35
8. Bajoria R, Gibson MJ, Ward S, Sooranna SR, Neilson JP, Westwood M. Placental regulation of insulin-tike growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome. J Ctin Endocrinolo Metab 2001;86:3150-3156
9. Westwood M, Gibson JM, Sooranna SR, Neilson JP, Bajoria R. Genes or placenta as modulator of fetal growth: Evidence from the insulin-like growth factor axis in twins with discordant growth. Mol Hum Reprod 2001;7:387-395
10. Allan GJ, Flint DJ, Patel K. Insulin-like growth factor axis during embryonic development. Reproduction 2001;122(1):31-39
11. Chard T. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 1994;4(3):91-100
12. Katz LEL, Cohen P. Growth factor regulation of fetal growth. Fetal and neonatal physiology, 2nd edition, WB Saunders 1998;2401-2409
13. Woods KA, Camacho-Hubner C, Barter D, Clark AJ, Savage MO. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr 1997;423:39-45
14. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73-82
15. DeChiarra T, Efstratiadis A, Robertson E. A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990;345:78-80
16. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutanst lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Developmental Biology 1996;177:517-573
17. Pandini G, Frasca F, Mineo R, Sciacca P, Vigneri R, Belfiore A. Insulin/ insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 2002;277:39684-39695
18. Siddle K, Soos MA, Field CE, Nave BT. Hybrid and atypical insulin/ insulin-like growth factor I receptors. Horm Res 1994;41;2:56-64; discussion 65
19. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945-948
20. Constância M, Angiolini E, Sandovici I, Smith P, Smith R, Kelsey G, Dean W, Ferguson-Smith A, Sibley CP, Reik W, Fowden A. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc Natl Acad Sci USA. 2005 Dec 27;102(52):19219-19224
21. Coan PM, Fowden AL, Constancia M, Ferguson Smith AC, Burton GJ, Sibley CP. Disproportional effects of Igf2 knockout on placental morphology and diffusional exchange characteristics in the mouse. J Physiol 2008 Aug 28
22. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I, Le Bouc Y. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005;37(9):1003-1007
23. Binder G, Seidel AK, Weber K, Haase M, Wollmann HA, Ranke MB, Eggermann T. IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus. J Clin Endocrinol Metab 2006;91(11):4709-4712
24. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3:662-673
25. Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 2000;24:88-91
26. Camacho-Hubner C, Woods KA, Clark AJ, Savage MO. Insulin-Like Growth Factor (IGF)-I Gene Deletion. Rev Endocr Metab Disord 2002;3(4):357-361
27. Woods KA, Camacho-Hubner C, Barter D, Clark AJ, Savage MO. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997;423:39-45
28. Bonapace G, Concolino D, Formicola S, Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. Journal of Medical Genetics 2003;40:913-917
29. Netchine I, Azzi S, Houang M, Netchine I, Azzi S, Houang M, Seurin D, Daubas C, Ricort J, Legay C, Perin L, Heirich R, Godeau F, Le Bouc Y. Partial IGF-I deficiency demonstrates the critical role of IGF-I in growth and brain development. Hormone Research 2006;65(Suppl.4):29
30. Murphy R, Baptista J, Holly J, Umpleby AM, Ellard S, Harries LW, Crolla J, Cundy T, Hatterstey AT. Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene. J Clin Endocrinol Metab 2008 Aug 26
31. Bessone S, Vidal F, Le Bouc Y, Epelbaum J, Bluet-Pajot MT, Darmon M. EMK protein kinase-null mice: dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways. Dev Biol 1999;214:87-101
32. Skalhegg BS, Huang Y, Su T, Idzerda RL, McKnight GS, Burton KA. Mutation of the Calpha subunit of PKA leads to growth retardation and sperm dysfunction. Mol Endocrinol 2002;16:630-639
33. Zhang P, McGrath B, Li S, Frank A, Zambito F, Reinert J, Gannon M, Ma K, McNaughton K, Cavener DR. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 2002;22:3864-3874
34. de Lacerda L, Carvalho JA, Stannard B, Werner H, Boguszewski MC, Sandrini R, Malozowski SN, Leroith D, Underwood LE. In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene. Clin Endocrinol (Oxf) 1999;51:541-550
35. de Lacerda L, Carvalho JA, Stannard B, Werner H, Boguszewski MC, Sandrini R, Malozowski SN, Leroith D, Underwood LE. In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene. Clin Endocrinot (Oxf) 1999;51:541-550
36. Abuzzahab MJ, Goddard A, Grigorescu F, Lautier C, Smith RJ, Chernausek SD. Human IGF-1 receptor mutations associated with intrauterine and post-natal growth retardation. Presentation at 82nd Annual Meeting of the Endocrine Society 2000
37. Tumer Z, Harboe TL, Blennow E, Kalscheuer VM, Tommerup N, Brondum-Nielsen K. Molecular cytogenetic characterization of ring chromosome 15 in three unrelated patients. Am J Med Genet A 2004;1;130(4):340-344
38. Accili D, Nakae J, Kim JJ, Park BC, Rother KI. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development. J Pediatr Endocrinol Metab 1999;12:475-485
39. Chard T. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 1994;4:91-100
40. Crystal RA, Giudice LC. Insulin-like growth factor binding protein profiles in human fetal cord sera: ontogeny during gestation and differences in newborns with intrauterine growth retardation and large for gestational age newborns. In Modern concepts of insulin-like growth factors. EM Spencer, editor. Elsevier. New York New York USA 1991;395-408
41. Verhaeghe J, Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA. C-peptide, insulin-like growth factors 1 and 3 and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993;169:89-97
42. Ostlund E, Bang P, Hagenas L, Gried G. Insulin-tike growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation. Hum Reprod 1997;12:840-844
43. Kajimura S, Aida K, Duan C. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci USA 2005;25;102(4):1240-1245 Epub 2005 Jan 11
44. Crossey PA, Pillai CC, Miell JP. Altered placental, development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Ctin Invest 2002; 110:411-418
45. Rajkumar K, Barron D, Lewitt M, Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995;136:4029-4034
46. Watson CS, Bialek P, Anzo M, Khosravi J, Yee SP, Han VK. Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology 2006;147(3):1175-1186
47. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and pre-term human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555
48. Tomislav M, Silva JV, Zengdun S, Gui Y, Suwanichkul A, Durham SK, Powell DR, Murphy LJ. Phenotypic manifestations of insulin-like growth factor binding protein-3 overexpression in Transgenic mice. Endocrinology 2001;142:1958-1967
49. Araki E, Lipes MA, Patti ME, Bruning JC, Haag 3rd B, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994;372:186-190
50. Monami G, Emiliozzi V, Morrione A. Grb10/Nedd4- mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization. J Cell Physiol 2008;216(2):426-437
51. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, Oxvig C, van Deursen J. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004;131(5):1187-1194
52. Sordella R, Classon M, Hu KQ, Matheson SF, Brouns MR, Fine B, Zhang L, Takami H, Yamada Y, Settleman J. Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development. Dev Cell 2002;2:553-565
53. Birnbaum MJ. RhoGAP: the next big thing for small mice? Dev Cell 2002;2:521-523
54. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pots HA, van Duijn CM. A potymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-642
55. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SWJ, Oostra BA, Pots HA, van Duijn CM. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002;359:1036-1037
56. Guoyao W, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr 2004; 134:2169-2172
57. Doherty AS, Mann MRW, Tremblay KD, Bartolomei MS, Schultz RM. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod 2000;62:1526-1535
58. Ozanne SE, Hales CN. Programming of glucose-insulin metabolism. Trends Endocrinol Metab 2002;13(9):368-373
59. Maison P, Balkau B, Simon D, Chanson P, Rosselin G, Eschwege E. Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. Brit Med J 1998;316:1132-1133
60. Barker DJ, Hates CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36(1):62-67
61. Harel, Z, Tannenbaum GS. Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res 1995;38(5):747-753
62. Radunovic N, Kuczynski E, Rosen T, Dukanac J, Petkovic S, Lockwood CJ. Plasma apolipoprotein A-I and B concentrations in growth retarded fetuses: a link between tow birth weight and adult atherosclerosis. J Clin Endocrinot Metab 2000;85:85-88
63. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI. Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis. Am J Physiol 2000;278: E700-E706
64. Yarbrough DE, Barrett-Connor E, Kritz-Silverstein D, Wingard DL. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo study. Diabetes Care 1998;21:1652-1658
65. Conde-Agudelo A, Belizan JM, Diaz-Rossetto JL. Epidemiology of fetal death in Latin America. Acta Obstet Gynecol 2000;5:371-378
66. Valez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP. Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia 1994;37:624-631
67. Witlin AG, Sibai BM. Hypertension in pregnancy: current concepts of preeclampsia. Annu Rev Med 1997;48:115-127
68. Jensen RB, Chellakooty M, Vietwerth S, Vaag A, Larsen T, Greisen G, Skakkebaek NE, Scheike T, Juul A. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insutin-like growth factor-I play a role? Horm Res 2003;60;3:136-148